Human Cell Atlas and LifeTime are joining efforts to contribute to the fight against the COVID-19 pandemic by creating a joint registry where scientists can share knowledge and other resources
Human Cell Atlas (HCA) and LifeTime are creating a common framework for openly sharing knowledge, tools, data, and other resources. Their aim is to enable in-depth analyses of how SARS-CoV-2 affects the human body and to search for solutions to mitigate the current health crisis.
By participating in a joint registry, members of the HCA, LifeTime and others will contribute their expertise and the scientific and technological power of single-cell analysis and data integration to unravel the intricacies of the interaction of SARS-CoV-2 with the cells and tissues of the human body.
On www.humancellatlas.org/covid-19 the HCA is providing analyses, data, preprints, and publications. The LifeTime collaboration will pursue this effort by identifying individuals at risk of developing severe symptoms of the disease COVID-19, and guiding treatments based on relevant biomarkers. At the same time, research within the framework of both initiatives will allow the systematic identification of new drug targets and vaccine strategies.
“In these unprecedented times, many LifeTimers are channeling their efforts into fighting the virus and the disease it causes: COVID-19. LifeTime itself is designed to identify cellular and molecular biomarkers that can guide the development of precise treatments – based on understanding how a disease progresses over time in many patients. Bringing together their own specific expertise today, HCA and LifeTime collaborations will offer answers to today’s challenges and prepare the world to reduce the impact of future health crisis,” said Dr Geneviève Almouzni and Professor Nikolaus Rajewsky, the LifeTime coordinators.
Dr Aviv Regev and Dr Sarah Teichmann, Human Cell Atlas Founding Co-Chairs, added: “COVID-19 has leveraged the efforts within the HCA community to collaborate, collect new data from COVID-19 patients, share data and analysis, and draw meaningful insights from the work already being done by our members. We are thrilled to have the opportunity to build on this unprecedented and rapid community building by teaming up with LifeTime to coordinate efforts and yield insights into COVID-19 as quickly as possible. By uniting our strengths and communities, we will have even greater power to chart a path forward for combating the pandemic.”
More information available here
Photo by Olav Ahrens Røtne on Unsplash
Metamaterials tuned by light
A new class of metamaterials sensitive to light showing varying elastic properties once stimulated by a blue-light laser